Mixing Sumatriptan: A Prospective Study of Stratified Care Using Multiple Formulations
Author:
- 4 October 2001
- journal article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 41 (9) , 862-866
Abstract
Objective.—To assess the acceptability, utility, and tolerability of a system of stratified care of acute migraine using multiple formulations of sumatriptan. Background.—Stratified care matches the treatment of a disease to its level of severity. Sumatriptan, with its multiple formulations, seems a logical option in a stratified care approach. Little data exists on the use of multiple formulations in a single patient population. Design and Methods.—A prospective, open‐label, outpatient study recruited patients from a single center during the period from January 1998 through June 1998. Entry criteria included International Headache Society migraine diagnostic codes 1.1 or 1.2 and an established response to sumatriptan tablets or nasal spray. Patients who enrolled were allowed to use subcutaneous sumatriptan as either primary or rescue therapy for individual migraine attacks. Results.—Two hundred eighteen (80%) of 273 patients on tablets and 40 (85%) of 47 patients on nasal spray enrolled. During a period of 6 months, 61% of the patients on tablets and 85% of the patients using the nasal spray used at least one subcutaneous dose of sumatriptan. This system was efficacious and well tolerated. The majority of injections were used as rescue treatments following a failed oral or nasal dose. Two percent withdrew due to lack of efficacy, and 6% withdrew due to adverse events; however, 92% professed satisfaction with subcutaneous sumatriptan as an available tool for migraine management. Conclusion.—A system of stratified care using multiple formulations of sumatriptan is efficacious, well tolerated, and preferable to a program involving a single form of the drug.Keywords
This publication has 15 references indexed in Scilit:
- Open-Labeled Long-Term Study of the Efficacy, Safety, and Tolerability of Subcutaneous Sumatriptan in Acute Migraine TreatmentCephalalgia, 1999
- Sumatriptan Injection and Tablets in Clinical Practice: Results of a Survey of 707 MigraineursHeadache: The Journal of Head and Face Pain, 1998
- A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacksNeurology, 1998
- Disability Assessment as a Basis for Stratified CareCephalalgia, 1998
- Oral and Subcutaneous Sumatriptan in the Acute Treatment of MigraineCephalalgia, 1997
- 311C90: Long-term efficacy and tolerability profile for the acute treatment of migraineNeurology, 1997
- A Within-Patient Comparison of Subcutaneous and Oral Sumatriptan in the Acute Treatment of Migraine in General PracticeCephalalgia, 1997
- Efficacy of subcutaneous sumatriptan in repeated episodes of migraineNeurology, 1993
- Treatment of Migraine Attacks with SumatriptanNew England Journal of Medicine, 1991
- Treatment of acute migraine with subcutaneous sumatriptan1991